PARIS & SAN FRANCISCO--(BUSINESS WIRE)--SpineVision® announced today that it has appointed Bertrand Lellouche as Chief Financial Officer (CFO) of SpineVision SA, effective immediately. Mr. Lellouche has more than 15 years of experience in international financial management, including financial control and communication in an international environment. Most recently, he was Vice President and Chief Financial Officer (CFO) at Biomedical Diagnostics (BMD), an immunodiagnostics company headquartered in France. Prior to BMD, Mr. Lellouche was Vice President of Finance & Operations for GenOdyssee, a French-based drug discovery company. He has held several other senior financial positions since 1989 with other leading companies—including Technomed (medical), Coflexip (oil services) and Vivendi-Environment—introducing each of these companies to the financial markets.
